NL262354A - - Google Patents

Info

Publication number
NL262354A
NL262354A NL262354DA NL262354A NL 262354 A NL262354 A NL 262354A NL 262354D A NL262354D A NL 262354DA NL 262354 A NL262354 A NL 262354A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL262354A publication Critical patent/NL262354A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NL262354D 1960-03-17 NL262354A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15549A US3039929A (en) 1960-03-17 1960-03-17 Stable isoproteronol compositions

Publications (1)

Publication Number Publication Date
NL262354A true NL262354A (en:Method)

Family

ID=21772038

Family Applications (1)

Application Number Title Priority Date Filing Date
NL262354D NL262354A (en:Method) 1960-03-17

Country Status (6)

Country Link
US (1) US3039929A (en:Method)
BE (1) BE601304A (en:Method)
BR (1) BR6127708D0 (en:Method)
FR (1) FR1235M (en:Method)
GB (1) GB963264A (en:Method)
NL (1) NL262354A (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629985A (en:Method) * 1962-11-29
US3274057A (en) * 1963-10-30 1966-09-20 Merck & Co Inc Stable hexylresorcinol compositions
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
GB2216794B (en) * 1988-03-22 1991-11-20 Fisons Plc Pharmaceuticals compositions
WO1997040679A1 (en) * 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2350435A (en) * 1942-05-11 1944-06-06 Claude R Wickard Derivatives of ascorbic acid
BE555319A (en:Method) * 1956-03-21 1900-01-01

Also Published As

Publication number Publication date
GB963264A (en) 1964-07-08
FR1235M (fr) 1962-04-09
BR6127708D0 (pt) 1973-07-03
US3039929A (en) 1962-06-19
BE601304A (fr) 1961-09-14

Similar Documents

Publication Publication Date Title
FI41049B (en:Method)
BE604833R (en:Method)
BE601704A (en:Method)
BE592862A (en:Method)
BE600682A (en:Method)
BE603355A (en:Method)
BE603525A (en:Method)
NL262354A (en:Method)
BE601783A (en:Method)
BE601752A (en:Method)
BE652428A (en:Method)
BE615115A (en:Method)
BE601636A (en:Method)
BE611387A (en:Method)
BE601201A (en:Method)
BE600875A (en:Method)
BE600872A (en:Method)
BE601189A (en:Method)
BE603195A (en:Method)
BE590786A (en:Method)
BE600609A (en:Method)
BE600101A (en:Method)
NL123343C (en:Method)
BE605950A (en:Method)
BE599759A (en:Method)